Molina Healthcare Stock Current Valuation
MHG Stock | 275.60 3.30 1.18% |
Valuation analysis of Molina Healthcare helps investors to measure Molina Healthcare's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Molina Healthcare's price fluctuation is very steady at this time. Calculation of the real value of Molina Healthcare is based on 3 months time horizon. Increasing Molina Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Molina Healthcare's intrinsic value may or may not be the same as its current market price of 275.60, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 275.6 | Real 252.74 | Hype 275.6 |
The intrinsic value of Molina Healthcare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Molina Healthcare's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Molina Healthcare helps investors to forecast how Molina stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Molina Healthcare more accurately as focusing exclusively on Molina Healthcare's fundamentals will not take into account other important factors: Molina Healthcare Company Current Valuation Analysis
Molina Healthcare's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Molina Healthcare Current Valuation | 14.16 B |
Most of Molina Healthcare's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Molina Healthcare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition |
In accordance with the recently published financial statements, Molina Healthcare has a Current Valuation of 14.16 B. This is much higher than that of the sector and significantly higher than that of the Current Valuation industry. The current valuation for all Germany stocks is notably lower than that of the firm.
Molina Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Molina Healthcare's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Molina Healthcare could also be used in its relative valuation, which is a method of valuing Molina Healthcare by comparing valuation metrics of similar companies.Molina Healthcare is currently under evaluation in current valuation category among its peers.
Molina Fundamentals
Current Valuation | 14.16 B | |||
Price To Book | 6.48 X | |||
Price To Sales | 0.63 X | |||
Revenue | 31.97 B | |||
EBITDA | 1.35 B | |||
Net Income | 792 M | |||
Total Debt | 2.18 B | |||
Cash Flow From Operations | 773 M | |||
Market Capitalization | 15.67 B | |||
Total Asset | 12.31 B | |||
Z Score | 6.2 | |||
Net Asset | 12.31 B |
About Molina Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Molina Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Molina Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Molina Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Molina Stock Analysis
When running Molina Healthcare's price analysis, check to measure Molina Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Molina Healthcare is operating at the current time. Most of Molina Healthcare's value examination focuses on studying past and present price action to predict the probability of Molina Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Molina Healthcare's price. Additionally, you may evaluate how the addition of Molina Healthcare to your portfolios can decrease your overall portfolio volatility.